The rationale is there, but the real-world results just dont compare to prescription GLP-1s
Experience better health outcomes with Wegovy, Oral Wegovy, Zepbound, or Foundayo
Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial. The Lancet Diabetes & Endocrinology, vol
SURMOUNT-1 enrolled adults with obesity or overweight with weight-related comorbidities, demonstrating that dual agonism could achieve weight loss results that approach those seen with bariatric surgery
Safety and effective usage come from medical supervision and adherence to prescribed doses
Why are retatrutide dose increases every 4 weeks instead of every 2 weeks